Agilon Health, Inc.

AGL Healthcare Medical Care Facilities

Agilon Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, down 2.11% from fiscal 2024. In the quarter to June 2026, revenue grew 7.15%, EPS grew 117.1%, free cash flow fell 50.2% and total debt fell 13.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

85.12 3.33 −3.76%
Market cap
$1.5B
P/E
0.0×
Fwd P/E
−33.1×
Dividend yield
—
F-score
3/9
Altman Z
1.45
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 3 2 4
ROE
(69.98%) (130.95%) (104.02%) (72.97%)
ROA
(16.72%) (26.04%) (20.63%) (14.06%)
ROIC
(781.56%) 0.00% 0.00% (34,218.16%)
Return on Tangible Assets
(248.00%) (857.67%) (480.83%) (177.67%)
Average Days of Receivables
58.74 41.45 56.42 65.34
Free Cash Flow per Share
(6.91) (8.99) (5.14) (6.34)
Free Cash Flow
(114.58) (148.87) (85.40) (105.98)
Other line items

Show all line items

Columns are period end dates